Skip to content
Home › 13F recaps › Q3 2026 › SNY

Which funds bought or sold SNY in Q3 2026?

Sanofi Sa Adr. 2 funds bought, 4 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$553M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold SNY, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (2)

FundChangeEst. $Now
Pzena
Value investor
Added+348.2%+$4M$5M
Maverick
Hedge fund
Added+98.2%+$2M$4M

Sold (4)

FundChangeEst. $Now
Dodge & Cox
Value investor
Trimmed-44.2%−$512M$646M
Balyasny
Quant & multi-strategy
Trimmed-95.9%−$95M$4M
Fisher Investments
Asset manager
Trimmed-9.7%−$42M$396M
GQG
Growth / crossover
Sold out−$4M—

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.